European Medicinal Cannabis Association (EUMCA) Appoints UK Professor Jones, CBE, FMedSci, as its new Chairman.

A long-standing member of the UK Government Regulatory Agency Medicines Commission and King’s College, London professor has been appointed as chairman of the European Medicinal Cannabis Association.

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman.

The European Medicinal Cannabis Association

The EUMCA, incorporated on 14 November 2019, was formally launched the following week at the MedCann World Forum 2019 in Malta, and represents the interests of ethical companies working in the supply and manufacture of medical cannabis.

Founding members include Bundesverband der Pharmazeutischen Industrie (BPI), Cannaflos, Comm-Op Europe, Ethical Medicines Industry Group (EMIG), IQANNA – the Pharmaceutical Division of Clever Leaves, Materia Ventures, MSSV, Panaxia and Tilray.

Professor Jones

In Professor Jones, the EUMCA will be welcoming an accomplished and distinguished scientist, policy expert and businessman who, in the course of his career, has made a central contribution to global health through his scientific research and development output.

As Group R&D Director at The Wellcome Foundation Ltd he was responsible for the development of AZT, Zovirax, Lamictal, Malarone and other medicines. He was a Director of Allergan Inc. (USA), and Director General of the Association of the British Pharmaceutical Industry (ABPI).

Sita Schubert, General Secretary of the European Medicinal Cannabis Association, commented: “We are honoured to have Professor Jones lead the EUMCA as we look to build on our mission to promote scientific medical research, and to bring a credible voice that drives and shapes policy in the standardised, ethical and sustainable use of medicinal cannabis across the region.

“EUMCA exists to help producers and manufacturers overcome challenges, such as meeting GMP standards, but with our aggregated experience in pharmaceuticals, biotech and government, we are also uniquely well placed to leverage best practice as we drive positive change and innovation.”

Professor Jones served for 12 years as a member of the UK Government Regulatory Agency Medicines Commission and as Chairman of the UK Government Advisory Group on Genetics Research.

Source:  https://www.healtheuropa.eu/london-professor-appointed-chairman-of-europe-medicinal-cannabis-body/96499/

Primary Sponsor

 


Karma Koala Podcast

Top Marijuana Blog